2m 2m 2m 2m 2m 2m 2m
LIPOCINE (LPCN)
NASDAQ
$2.19-$0.06 (-2.89%)
Price as of Jun 03, 2026 4:10 PM EDT- $18.5MMarket Cap
- -29.69%1-Year Change
- BiotechnologyIndustry
LIPOCINE (LPCN)
$2.19-$0.06 (-2.89%)
LPCN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.25 | ||
Change | -$0.03 (-1.32%) | ||
Open | $2.27 | ||
High | $2.32 | ||
Low | $2.18 | ||
Previous Close | $2.28 | ||
Volume | 140,476 | ||
30-Day Average Volume | 100,300 | ||
1-Week Change | -0.44% | ||
1-Month Change | -3.43% | ||
1-Year Change | -29.69% | ||
3-Year Change | -50.00% | ||
5-Year Change | -89.15% | ||
Fundamentals | |||
Shares Outstanding | 8.2M | ||
Total Assets | $25.4M | ||
Market Cap | $18.5M | ||
Enterprise Value | $13.5M | ||
Period: QTR TTM FY | |||
Revenue | $119,397.00 | ||
Net Income | -$3.7M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$3.7M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $22.7M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 113 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 17 | ||
Last Split Date | 05/12/2023 | ||
Earnings & Revenue